Randomised clinical trial: vonoprazan, a novel potassium‐competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis

BACKGROUND: Vonoprazan is a novel potassium‐competitive acid blocker which may provide clinical benefit in acid‐related disorders. AIM: To verify the non‐inferiority of vonoprazan vs. lansoprazole in patients with erosive oesophagitis (EE), and to establish its long‐term safety and efficacy as maint...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Aliment Pharmacol Ther
Hauptverfasser: Ashida, K., Sakurai, Y., Hori, T., Kudou, K., Nishimura, A., Hiramatsu, N., Umegaki, E., Iwakiri, K.
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2015
Schlagworte:
Randomised Clinical Trial
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4738414/
https://ncbi.nlm.nih.gov/pubmed/26559637
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.13461
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge